Sagentia Group plc ("Sagentia" or "Company")
AGM Statement
At the Annual General Meeting of the Company this morning, Martyn Ratcliffe, Chairman, will provide the following update on the year to date.
"The actions taken by Brent Hudson, Chief Executive Officer, and his team in 2009 are proving successful and the current year has started well, with revenue and profitability ahead of the Board's expectations.
On 18 May 2010, the Company announced a conditional Placing of 20,000,000 shares at 40 pence per share with certain institutional and other investors to raise £8.0 million before expenses. This Placing, at a premium to the share price prior to the Placing, will enable the Company to pursue acquisition opportunities complementary to the Group's current business operations. Details of the Placing are set out in the Circular posted to Shareholders on 18 May 2010."
For further information, please contact:
Sagentia Group plc |
|
Martyn Ratcliffe, Chairman |
Tel: +44 1223 875 200 |
Brent Hudson, CEO |
|
Guy McCarthy, CFO
|
|
Arbuthnot Securities Limited |
|
Nick Tulloch/Paul Gillam |
Tel: +44 20 7012 2000 |
Notes for Editors:
About Sagentia
Sagentia is a technology and product development company that creates, develops and delivers business opportunities, products and services for its clients.
Established in 1986, Sagentia operates in the medical, industrial products and consumer products sectors worldwide. It develops new technologies, products and services that change the basis of competition. The company also assists business leaders to create strategies for technology, innovation and growth.
Sagentia's resources are situated in state-of-the-art facilities in Europe, the USA, and China. The Group is listed on AIM (ti: SAG.L).
www.sagentia.com/investors
info@sagentia.com